SJR004 is a Colorado joint resolution that designates the week of September 20 through September 26, 2026, as "Frontotemporal Degeneration Awareness Week." The resolution is primarily commemorative and educational: it explains what frontotemporal degeneration (FTD) is, describes its symptoms and variants, and highlights the challenges of diagnosis, treatment, caregiving, and research. It also notes the connection between FTD and broader dementia awareness efforts, including the Colorado Department of Public Health and Environment’s "Talk About Dementia" campaign and the national plan addressing Alzheimer’s disease and related dementias.
The resolution emphasizes that FTD is a terminal, incurable neurodegenerative disease that often affects people in midlife, can be misdiagnosed, and can impose significant emotional and financial burdens on patients and families. It calls attention to the need for greater public awareness, advocacy, and support for research, and it directs that a copy of the resolution be sent to the Association for Frontotemporal Degeneration.
Impact
Because SJR004 is a joint resolution, it does not amend Colorado statutes, create new regulatory duties, or appropriate funds. Its legal effect is limited to formally recognizing a week of awareness in the state and expressing legislative support for education and advocacy around FTD. The practical impact is symbolic but potentially meaningful for affected families, caregivers, clinicians, and advocacy organizations by elevating visibility of a relatively underrecognized dementia.
Sentiment
The bill appears to have broad bipartisan support and little to no opposition. The recorded votes were unanimous in both chambers, with the Senate passing the resolution 31-0 and the House passing it 56-0. That voting history suggests strong agreement with the resolution’s public-health and awareness goals.
Contention
No notable substantive controversy appears in the available record. The resolution is nonbinding and largely ceremonial, so there is no apparent dispute over legal mandates, funding, or enforcement. Any discussion implied by the text centers on the importance of recognizing FTD as a serious and often misdiagnosed disease, rather than on competing policy positions.